ImmunoGen surges after cancer drug study hits ‘home run’ – Reuters

Leave a Comment / Business / By
  1. ImmunoGen surges after cancer drug study hits ‘home run’Reuters
  2. ELAHERE® Demonstrates Overall Survival Benefit in Phase 3 MIRASOL Trial in Patients With Platinum-Resistant FRα-Positive Ovarian CancerYahoo finance
  3. ImmunoGen Touts Additional Positive Ovarian Cancer Drug Data, Seeks Expanded-Use Approval, Stock SoaGasoline
  4. Why is ImmunoGen (IMGN) stock up 125% today?InvestorPlace
  5. ImmunoGen touts additional positive data on ovarian cancer drug, seeks expanded use approval, stock soarsYahoo finance
  6. See full coverage on Google News

Leave a Comment

Your email address will not be published. Required fields are marked *